Postoperative Radiation After Radical Prostatectomy

Eric C. Ko, Anthony L. Michaud, Richard K Valicenti

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

A total of 3 randomized clinical trials have demonstrated a significant clinical benefit with adjuvant radiation in patients with high-risk prostate cancer after radical prostatectomy, with each showing improved biochemical control outcomes, and one trial (SWOG 8794) also demonstrating increased overall survival. How broadly these results have informed clinical practice has evolved over time, given the widespread availability of ultrasensitive prostate-specific antigen level testing and increased awareness that the high-risk patients are not a uniform cohort. In this review, we discuss the evidence from published and ongoing trials as well as current controversies, focusing on unanswered questions such as when postoperative radiation should be offered and whether the inclusion of androgen-deprivation therapy improves clinical outcomes. The emerging interest in genomic prediction tools and the enhanced sensitivity of novel imaging modalities should offer strategies to improve patient selection, which would help to identify men who may benefit from postoperative radiation while avoiding unnecessary treatment and toxicities in other men.

Original languageEnglish (US)
Pages (from-to)50-66
Number of pages17
JournalSeminars in Radiation Oncology
Volume27
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Prostatectomy
Radiation
Prostate-Specific Antigen
Patient Selection
Androgens
Prostatic Neoplasms
Randomized Controlled Trials
Survival
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Postoperative Radiation After Radical Prostatectomy. / Ko, Eric C.; Michaud, Anthony L.; Valicenti, Richard K.

In: Seminars in Radiation Oncology, Vol. 27, No. 1, 01.01.2017, p. 50-66.

Research output: Contribution to journalReview article

Ko, Eric C. ; Michaud, Anthony L. ; Valicenti, Richard K. / Postoperative Radiation After Radical Prostatectomy. In: Seminars in Radiation Oncology. 2017 ; Vol. 27, No. 1. pp. 50-66.
@article{85f79856e182400d90cf47bdad60a613,
title = "Postoperative Radiation After Radical Prostatectomy",
abstract = "A total of 3 randomized clinical trials have demonstrated a significant clinical benefit with adjuvant radiation in patients with high-risk prostate cancer after radical prostatectomy, with each showing improved biochemical control outcomes, and one trial (SWOG 8794) also demonstrating increased overall survival. How broadly these results have informed clinical practice has evolved over time, given the widespread availability of ultrasensitive prostate-specific antigen level testing and increased awareness that the high-risk patients are not a uniform cohort. In this review, we discuss the evidence from published and ongoing trials as well as current controversies, focusing on unanswered questions such as when postoperative radiation should be offered and whether the inclusion of androgen-deprivation therapy improves clinical outcomes. The emerging interest in genomic prediction tools and the enhanced sensitivity of novel imaging modalities should offer strategies to improve patient selection, which would help to identify men who may benefit from postoperative radiation while avoiding unnecessary treatment and toxicities in other men.",
author = "Ko, {Eric C.} and Michaud, {Anthony L.} and Valicenti, {Richard K}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.semradonc.2016.08.005",
language = "English (US)",
volume = "27",
pages = "50--66",
journal = "Seminars in Radiation Oncology",
issn = "1053-4296",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Postoperative Radiation After Radical Prostatectomy

AU - Ko, Eric C.

AU - Michaud, Anthony L.

AU - Valicenti, Richard K

PY - 2017/1/1

Y1 - 2017/1/1

N2 - A total of 3 randomized clinical trials have demonstrated a significant clinical benefit with adjuvant radiation in patients with high-risk prostate cancer after radical prostatectomy, with each showing improved biochemical control outcomes, and one trial (SWOG 8794) also demonstrating increased overall survival. How broadly these results have informed clinical practice has evolved over time, given the widespread availability of ultrasensitive prostate-specific antigen level testing and increased awareness that the high-risk patients are not a uniform cohort. In this review, we discuss the evidence from published and ongoing trials as well as current controversies, focusing on unanswered questions such as when postoperative radiation should be offered and whether the inclusion of androgen-deprivation therapy improves clinical outcomes. The emerging interest in genomic prediction tools and the enhanced sensitivity of novel imaging modalities should offer strategies to improve patient selection, which would help to identify men who may benefit from postoperative radiation while avoiding unnecessary treatment and toxicities in other men.

AB - A total of 3 randomized clinical trials have demonstrated a significant clinical benefit with adjuvant radiation in patients with high-risk prostate cancer after radical prostatectomy, with each showing improved biochemical control outcomes, and one trial (SWOG 8794) also demonstrating increased overall survival. How broadly these results have informed clinical practice has evolved over time, given the widespread availability of ultrasensitive prostate-specific antigen level testing and increased awareness that the high-risk patients are not a uniform cohort. In this review, we discuss the evidence from published and ongoing trials as well as current controversies, focusing on unanswered questions such as when postoperative radiation should be offered and whether the inclusion of androgen-deprivation therapy improves clinical outcomes. The emerging interest in genomic prediction tools and the enhanced sensitivity of novel imaging modalities should offer strategies to improve patient selection, which would help to identify men who may benefit from postoperative radiation while avoiding unnecessary treatment and toxicities in other men.

UR - http://www.scopus.com/inward/record.url?scp=85006792214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006792214&partnerID=8YFLogxK

U2 - 10.1016/j.semradonc.2016.08.005

DO - 10.1016/j.semradonc.2016.08.005

M3 - Review article

C2 - 27986212

AN - SCOPUS:85006792214

VL - 27

SP - 50

EP - 66

JO - Seminars in Radiation Oncology

JF - Seminars in Radiation Oncology

SN - 1053-4296

IS - 1

ER -